| Continuing to Play Me-Too - Motley Fool |
|
|
Motley Fool Many diabetics have renal impairment, which can affect the efficacy of a drug. Having that information on the label is important. But Januvia's label already contains information about patients with renal impairment, so Onglyza isn't offering anything |